Biologic protease inhibitors as novel therapeutic agents.
about
Bowman-Birk inhibitors from legumes as colorectal chemopreventive agents.Detection of protease activities by flash chronopotentiometry using a reversible polycation-sensitive polymeric membrane electrode.Antibody targeting of Cathepsin S induces antibody-dependent cellular cytotoxicity.Bispecific antibody derivatives with restricted binding functionalities that are activated by proteolytic processing.Purification and Characterization of a Novel Kazal-Type Trypsin Inhibitor from the Leech of Hirudinaria manillensisIdentification and pre-clinical testing of a reversible cathepsin protease inhibitor reveals anti-tumor efficacy in a pancreatic cancer model.A Trypsin Inhibitor from Tamarind Reduces Food Intake and Improves Inflammatory Status in Rats with Metabolic Syndrome Regardless of Weight LossStructural and mechanistic insight into how antibodies inhibit serine proteases.Proteases as therapeutics.Design and evaluation of radiolabeled tracers for tumor imaging.Targeting kallikrein-related peptidases in prostate cancer.Recent advances on plasmin inhibitors for the treatment of fibrinolysis-related disorders.Antibody mimetics: promising complementary agents to animal-sourced antibodies.Cold-adapted proteases as an emerging class of therapeutics.Molecular cloning, expression, and anti-tumor activity of a novel serine protease from Arenicola cristata.Interactions of a low molecular weight inhibitor from Streptomyces sp. MBR04 with human cathepsin D: implications in mechanism of inactivation.Serine protease inhibitors to treat inflammation: a patent review (2011-2016).Antibody Mimetics, Peptides, and Peptidomimetics.The proteolytic activity of MT4-MMP is required for its pro-angiogenic and pro-metastatic promoting effects.Natural Inhibitors of Snake Venom Metallopeptidases
P2860
Q34036615-2CDCA1EE-CCBE-42F4-959D-9B5350B1DC15Q35074826-F311EDF3-AAED-4712-8D05-ED04484E0081Q35704154-4F982464-488A-4771-A80E-FAD63606B1F0Q36254477-9ED267DF-D552-4BD3-864D-500CB5277B7DQ37209006-032EB7AC-E102-4FC4-B497-52D8DCD8CB9BQ37270829-20364C2B-F30E-4B60-B856-4E1E56280E12Q37373744-C4C04BFB-0870-4439-900E-A60F7CFBB26FQ37779571-8904AC6B-7AE2-4548-A8B4-7B815173384DQ37853216-404B960E-4DE2-47F4-8575-C40EBFE8DE69Q38137253-B0542E4C-17BA-41C8-81AF-5800A9D3D5B2Q38191293-69F87B1D-C7E8-47F5-9E55-AD5B3934EF1BQ38198582-E53AB3C2-850B-4F20-AA17-36CAF7C1346FQ38255176-B57F709E-E70B-4E08-877D-DB81A45D2246Q39410680-DFE99F28-F926-49D3-8B9A-BBDEDBF9620FQ42653146-3858CD47-BE19-4E06-907D-0EC1FCA10A62Q46849968-FFCBE969-FEA3-4910-908E-32F05DA3F87CQ47368493-B8B9D153-2EAE-4E73-A7E1-64CD96D919ECQ50981072-7022CD01-7090-4AE7-9217-16869F925CA7Q51823101-663255AD-4921-46C6-9E9D-93EB681A605CQ57450500-7CDEA5EE-303B-429B-825A-D1E0C8DD12CD
P2860
Biologic protease inhibitors as novel therapeutic agents.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Biologic protease inhibitors as novel therapeutic agents.
@en
Biologic protease inhibitors as novel therapeutic agents.
@nl
type
label
Biologic protease inhibitors as novel therapeutic agents.
@en
Biologic protease inhibitors as novel therapeutic agents.
@nl
prefLabel
Biologic protease inhibitors as novel therapeutic agents.
@en
Biologic protease inhibitors as novel therapeutic agents.
@nl
P1433
P1476
Biologic protease inhibitors as novel therapeutic agents.
@en
P2093
Christopher J Scott
Clifford C Taggart
P304
P356
10.1016/J.BIOCHI.2010.03.010
P577
2010-03-24T00:00:00Z